In this podcast Dr Megan O’Hare talks to Francesca La Frenais, and Dr Penny Rapaport about the MARQUE Study, and how their work is helping us to understand what causes agitation and how the interventions tested in this study are improving quality of life for those living with dementia, and helping carers.
Clinical Psychologist, developing & testing of psychosocial interventions in dementia care
Crowd sourcing funding for start-ups and business has become the norm, but could the same system be used for science or dementia research?
This review, aims to assess the ability of CSF tau biomarkers (t-tau and p-tau) and the CSF tau (t-tau or p-tau)/ABeta ratio to enable the detection of Alzheimer’s disease pathology in patients with mild cognitive impairment (MCI).
Regular Podcast Host and one of the Dementia Researcher website leads
To beat the stiff competition, highlight your skills in collaboration, teamwork and meeting deadlines.
Research assistant and PhD student at University College London
Want to communicate your health research in a better way in 2018? This resource from The Health Foundation is the tool you need.
Parkinson’s disease comes in many flavors, posing a challenge for clinical trials. Knowing how the disease progresses may improve chances of success. A longitudinal study from the LRRK2 Ashkenazi Jewish Consortium provides just such data.
A unique perspective encouraged by science; the ability to slow down, freeze-frame, and dissect things.
